Top

Published in:

01-05-2018 | Review

Neurogenic inflammation and its role in migraine

Author: Roshni Ramachandran

Published in: Seminars in Immunopathology | Issue 3/2018

Abstract

The etiology of migraine pain involves sensitized meningeal afferents that densely innervate the dural vasculature. These afferents, with their cell bodies located in the trigeminal ganglion, project to the nucleus caudalis, which in turn transmits signals to higher brain centers. Factors such as chronic stress, diet, hormonal fluctuations, or events like cortical spreading depression can generate a state of “sterile inflammation” in the intracranial meninges resulting in the sensitization and activation of trigeminal meningeal nociceptors. This sterile inflammatory phenotype also referred to as neurogenic inflammation is characterized by the release of neuropeptides (such as substance P, calcitonin gene related peptide) from the trigeminal innervation. This release leads to vasodilation, plasma extravasation secondary to capillary leakage, edema, and mast cell degranulation. Although neurogenic inflammation has been observed and extensively studied in peripheral tissues, its role has been primarily investigated in the genesis and maintenance of migraine pain. While some aspects of neurogenic inflammation has been disregarded in the occurrence of migraine pain, targeted analysis of factors have opened up the possibilities of a dialogue between the neurons and immune cells in driving such a sterile neuroinflammatory state in migraine pathophysiology.

Stovner L, Hagen K, Jensen R et al (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193–210. https://doi.org/10.1111/j.1468-2982.2007.01288.x PubMedCrossRef

Vetvik KG, MacGregor EA (2017) Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 16:76–87. https://doi.org/10.1016/S1474-4422(16)30293-9 PubMedCrossRef

Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J (1995) Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol 24:612–618PubMedCrossRef

Olesen J (2016) From ICHD-3 beta to ICHD-3. Cephalalgia 36:401–402. https://doi.org/10.1177/0333102415596446 PubMedCrossRef

Antonaci F, Ghiotto N, Wu S et al (2016) Recent advances in migraine therapy. Springerplus 5:637. https://doi.org/10.1186/s40064-016-2211-8 PubMedPubMedCentralCrossRef

Reuter U (2014) Anti-CGRP antibodies: a new approach to migraine prevention. Lancet Neurol 13:857–859. https://doi.org/10.1016/S1474-4422(14)70126-7 PubMedCrossRef

Ray BS, Wolff HG (1940) Experimental studies on headache: pain-sensitive structures of the head and their significance in headache. Arch Surg 41:813–856. https://doi.org/10.1001/archsurg.1940.01210040002001 CrossRef

McNaughton FL, Feindel WH (1997) Innervation of intracranial structures: a reappraisal. In: Physiological Aspects of Clinical Neurology, Oxford: Blackwell Scientific Publications, England, pp 270–293

Procacci P, Maresca M (1999) Referred pain from somatic and visceral structures. Curr Rev Pain 3:96–99. https://doi.org/10.1007/s11916-999-0032-y CrossRef

10.

Andres KH, Düring Von M, Muszynski K, Schmidt RF (1987) Nerve fibres and their terminals of the dura mater encephali of the rat. Anat Embryol 175:289–301PubMedCrossRef

11.

Arnold F (1831) Der Kopftheil des vegetativen Nervensystems beim Menschen: in anatomischer und physiologischer Hinsicht

12.

Luschka H (1856) Die Altersveränderungen der Zwischenwirbelknorpel. Arch Pathol Anat 9:311–327. https://doi.org/10.1007/BF01879395 CrossRef

13.

Grzybowski JL (1931) Innervation de la dure—mére cranienne chez l’homme. Arch Anat Histol Embryol 14:387–428

14.

Penfield W (1940) Dural headache and Innervation of the dura mater. Arch Neurol Psychiatr 44:43–75. https://doi.org/10.1001/archneurpsyc.1940.02280070051003 CrossRef

15.

Steiger HJ, Meakin CJ (1984) The meningeal representation in the trigeminal ganglion—an experimental study in the cat. Headache 24:305–309PubMedCrossRef

16.

Mayberg MR, Zervas NT, Moskowitz MA (1984) Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol 223:46–56. https://doi.org/10.1002/cne.902230105 PubMedCrossRef

17.

Uddman R, Hara H, Edvinsson L (1989) Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry. J Auton Nerv Syst 26:69–75PubMedCrossRef

18.

Strassman AM, Potrebic S, Maciewicz RJ (1994) Anatomical properties of brainstem trigeminal neurons that respond to electrical stimulation of dural blood vessels. J Comp Neurol 346:349–365. https://doi.org/10.1002/cne.903460304 PubMedCrossRef

19.

Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964–982. https://doi.org/10.1152/jn.1998.79.2.964 PubMedCrossRef

20.

Strassman AM, Weissner W, Williams M et al (2004) Axon diameters and intradural trajectories of the dural innervation in the rat. J Comp Neurol 473:364–376. https://doi.org/10.1002/cne.20106 PubMedCrossRef

21.

Keller JT, Dimlich RV, Zuccarello M et al (1991) Influence of the sympathetic nervous system as well as trigeminal sensory fibres on rat dural mast cells. Cephalalgia 11:215–221. https://doi.org/10.1046/j.1468-2982.1991.1105215.x PubMedCrossRef

22.

Messlinger K, Hanesch U, Baumgärtel M et al (1993) Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity. Anat Embryol 188:219–237PubMedCrossRef

23.

Levy D, Strassman AM (2002) Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura. J Neurophysiol 88:3021–3031. https://doi.org/10.1152/jn.00029.2002 PubMedCrossRef

24.

Zhang X, Strassman AM, Novack V et al (2016) Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’ responses to stimulation of TRPV1 and TRPA1 channels: are we getting closer to solving this puzzle? Cephalalgia 36:875–886. https://doi.org/10.1177/0333102416636843 PubMedPubMedCentralCrossRef

25.

Schueler M, Messlinger K, Dux M et al (2013) Extracranial projections of meningeal afferents and their impact on meningeal nociception and headache. Pain 154:1622–1631. https://doi.org/10.1016/j.pain.2013.04.040 PubMedCrossRef

26.

Edvinsson L, Gulbenkian S, Barroso CP et al (1998) Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotility. Peptides 19:1213–1225PubMedCrossRef

27.

Edvinsson L, Uddman R (1981) Adrenergic, cholinergic and peptidergic nerve fibres in dura mater—involvement in headache? Cephalalgia 1:175–179. https://doi.org/10.1046/j.1468-2982.1981.0104175.x PubMedCrossRef

28.

Keller JT, Marfurt CF (1991) Peptidergic and serotoninergic innervation of the rat dura mater. J Comp Neurol 309:515–534. https://doi.org/10.1002/cne.903090408 PubMedCrossRef

29.

Drummond PD, Lance JW (1992) Pathological sweating and flushing accompanying the trigeminal lacrimal reflex in patients with cluster headache and in patients with a confirmed site of cervical sympathetic deficit. Evidence for parasympathetic cross-innervation. Brain 115(Pt 5):1429–1445PubMedCrossRef

30.

Drummond PD (1994) Sweating and vascular responses in the face: normal regulation and dysfunction in migraine, cluster headache and harlequin syndrome. Clin Auton Res 4:273–285PubMedCrossRef

31.

Edvinsson L, Goadsby PJ (1994) Neuropeptides in migraine and cluster headache. Cephalalgia 14:320–327. https://doi.org/10.1046/j.1468-2982.1994.1405320.x PubMedCrossRef

32.

Fang HC (1961) Cerebral arterial innervations in man. Arch Neurol 4:651–656PubMedCrossRef

33.

Keller JT, Saunders MC, Beduk A, Jollis JG (1985) Innervation of the posterior fossa dura of the cat. Brain Res Bull 14:97–102PubMedCrossRef

34.

Schueler M, Neuhuber WL, De Col R, Messlinger K (2014) Innervation of rat and human dura mater and pericranial tissues in the parieto-temporal region by meningeal afferents. Headache 54:996–1009. https://doi.org/10.1111/head.12371 PubMedCrossRef

35.

Bove GM, Moskowitz MA (1997) Primary afferent neurons innervating guinea pig dura. J Neurophysiol 77:299–308. https://doi.org/10.1152/jn.1997.77.1.299 PubMedCrossRef

36.

Lv X, Wu Z, Li Y (2014) Innervation of the cerebral dura mater. Neuroradiol J 27:293–298. https://doi.org/10.15274/NRJ-2014-10052 PubMedPubMedCentralCrossRef

37.

Düring Von M, Bauersachs M, Böhmer B et al (1990) Neuropeptide Y- and substance P-like immunoreactive nerve fibers in the rat dura mater encephali. Anat Embryol 182:363–373CrossRef

38.

Strassman AM, Levy D (2006) Response properties of dural nociceptors in relation to headache. J Neurophysiol 95:1298–1306. https://doi.org/10.1152/jn.01293.2005 PubMedCrossRef

39.

Strassman AM, Raymond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Published online: 12 December 1996; |384:560–564. https://doi.org/10.1038/384560a0

40.

Dostrovsky JO, Davis KD, Kawakita K (1991) Central mechanisms of vascular headaches. Can J Physiol Pharmacol 69:652–658PubMedCrossRef

41.

Blau JN, Dexter SL (1981) The site of pain origin during migraine attacks. Cephalalgia 1:143–147. https://doi.org/10.1046/j.1468-2982.1981.0103143.x PubMedCrossRef

42.

Bahns E, Ernsberger U, Jänig W, Nelke A (1986) Discharge properties of mechanosensitive afferents supplying the retroperitoneal space. Pflugers Arch 407:519–525PubMedCrossRef

43.

Torebjörk HE, LaMotte RH, Robinson CJ (1984) Peripheral neural correlates of magnitude of cutaneous pain and hyperalgesia: simultaneous recordings in humans of sensory judgments of pain and evoked responses in nociceptors with C-fibers. J Neurophysiol 51:325–339. https://doi.org/10.1152/jn.1984.51.2.325 PubMedCrossRef

44.

Saper CB, Breder CD (1994) The neurologic basis of fever. N Engl J Med 330:1880–1886. https://doi.org/10.1056/NEJM199406303302609 PubMedCrossRef

45.

Schepelmann K, Ebersberger A, Pawlak M et al (1999) Response properties of trigeminal brain stem neurons with input from dura mater encephali in the rat. Neuroscience 90:543–554PubMedCrossRef

46.

Taiwo YO, Levine JD (1991) Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 44:131–135. https://doi.org/10.1016/0306-4522(91)90255-M PubMedCrossRef

47.

Levine JD (1999) Peripheral mechanisms of inflammatory pain. In: Wall PD, Melzack R (ed) Textbook of Pain. Churchill Livingstone, London, pp 59–84

48.

Lopshire JC, Nicol GD (1998) The cAMP transduction cascade mediates the prostaglandin E2 enhancement of the capsaicin-elicited current in rat sensory neurons: Whole-cell and single-channel studies. J Neurosci 18:6081–6092PubMedCrossRef

49.

Pitchford S, Levine JD (1991) Prostaglandins sensitize nociceptors in cell culture. Neurosci Lett 132:105–108PubMedCrossRef

50.

Brain SD, Cox HM (2006) Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol 147(Suppl 1):S202–S211. https://doi.org/10.1038/sj.bjp.0706461 PubMedPubMedCentralCrossRef

51.

Eftekhari S, Warfvinge K, Blixt FW, Edvinsson L (2013) Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. J Pain 14:1289–1303. https://doi.org/10.1016/j.jpain.2013.03.010 PubMedCrossRef

52.

Uddman R, Goadsby PJ, Jansen I, Edvinsson L (1993) PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow. J Cereb Blood Flow Metab 13:291–297. https://doi.org/10.1038/jcbfm.1993.36 PubMedCrossRef

53.

Ebersberger A (2001) Physiology of meningeal innervation: aspects and consequences of chemosensitivity of meningeal nociceptors. Microsc Res Tech 53:138–146. https://doi.org/10.1002/jemt.1078 PubMedCrossRef

54.

Edvinsson L, Elsås T, Suzuki N et al (2001) Origin and co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat. Microsc Res Tech 53:221–228. https://doi.org/10.1002/jemt.1086 PubMedCrossRef

55.

Bae JY, Kim JH, Cho YS et al (2015) Quantitative analysis of afferents expressing substance P, calcitonin gene-related peptide, isolectin B4, neurofilament 200, and peripherin in the sensory root of the rat trigeminal ganglion. J Comp Neurol 523:126–138. https://doi.org/10.1002/cne.23672 PubMedCrossRef

56.

Edvinsson L, Hara H, Uddman R (1989) Retrograde tracing of nerve fibers to the rat middle cerebral artery with true blue: colocalization with different peptides. J Cereb Blood Flow Metab 9:212–218. https://doi.org/10.1038/jcbfm.1989.31 PubMedCrossRef

57.

Eftekhari S, Salvatore CA, Johansson S et al (2015) Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood–brain barrier. Brain Res 1600:93–109. https://doi.org/10.1016/j.brainres.2014.11.031 PubMedCrossRef

58.

Xiao Y, Richter JA, Hurley JH (2008) Release of glutamate and CGRP from trigeminal ganglion neurons: role of calcium channels and 5-HT1 receptor signaling. Mol Pain 4:12. https://doi.org/10.1186/1744-8069-4-12 PubMedPubMedCentralCrossRef

59.

Battaglia G, Rustioni A (1988) Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey. J Comp Neurol 277:302–312. https://doi.org/10.1002/cne.902770210 PubMedCrossRef

60.

Saito A, Lee TJ (1987) Serotonin as an alternative transmitter in sympathetic nerves of large cerebral arteries of the rabbit. Circ Res 60:220–228PubMedCrossRef

61.

De Felice M, Ossipov MH, Wang R et al (2010) Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. Brain 133:2475–2488. https://doi.org/10.1093/brain/awq159 PubMedPubMedCentralCrossRef

62.

Ramachandran R, Ploug KB, Hay-Schmidt A et al (2010) Nitric oxide synthase (NOS) in the trigeminal vascular system and other brain structures related to pain in rats. Neurosci Lett 484:192–196. https://doi.org/10.1016/j.neulet.2010.08.050 PubMedCrossRef

63.

Ramachandran R, Bhatt DK, Ploug KB et al (2014) Nitric oxide synthase, calcitonin gene-related peptide and NK-1 receptor mechanisms are involved in GTN-induced neuronal activation. Cephalalgia 34:136–147. https://doi.org/10.1177/0333102413502735 PubMedCrossRef

64.

Reuter U, Bolay H, Jansen-Olesen I et al (2001) Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 124:2490–2502PubMedCrossRef

65.

Strecker T, Dux M, Messlinger K (2002) Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow. J Vasc Res 39:489–496. https://doi.org/10.1159/000067206 PubMedCrossRef

66.

Bellamy J, Bowen EJ, Russo AF, Durham PL (2006) Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci 23:2057–2066. https://doi.org/10.1111/j.1460-9568.2006.04742.x PubMedPubMedCentralCrossRef

67.

Strecker T, Dux M, Messlinger K (2002) Increase in meningeal blood flow by nitric oxide—interaction with calcitonin gene-related peptide receptor and prostaglandin synthesis inhibition. Cephalalgia 22:233–241. https://doi.org/10.1046/j.1468-2982.2002.00356.x PubMedCrossRef

68.

Zhang X-C, Kainz V, Jakubowski M et al (2009) Localization of COX-1 and COX-2 in the intracranial dura mater of the rat. Neurosci Lett 452:33–36. https://doi.org/10.1016/j.neulet.2009.01.032 PubMedPubMedCentralCrossRef

69.

Gupta S, Amrutkar DV, Mataji A et al (2010) Evidence for CGRP re-uptake in rat dura mater encephali. Br J Pharmacol 161:1885–1898. https://doi.org/10.1111/j.1476-5381.2010.01012.x PubMedPubMedCentralCrossRef

70.

Wadel K, Neher E, Sakaba T (2007) The coupling between synaptic vesicles and Ca2+ channels determines fast neurotransmitter release. Neuron 53:563–575. https://doi.org/10.1016/j.neuron.2007.01.021 PubMedCrossRef

71.

Geppert M, Goda Y, Hammer RE et al (1994) Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell 79:717–727PubMedCrossRef

72.

Fernández-Chacón R, Königstorfer A, Gerber SH et al (2001) Synaptotagmin I functions as a calcium regulator of release probability. Nature 410:41–49. https://doi.org/10.1038/35065004 PubMedCrossRef

73.

Peroutka SJ (2005) Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 5:304–311. https://doi.org/10.1124/mi.5.5.10 PubMedCrossRef

74.

Kowalski ML, Sliwinska-Kowalska M, Kaliner MA (1990) Neurogenic inflammation, vascular permeability, and mast cells. II Additional evidence indicating that mast cells are not involved in neurogenic inflammation. J Immunol 145:1214–1221PubMed

75.

Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC (1991) Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience 44:97–112PubMedCrossRef

76.

Markowitz S, Saito K, Moskowitz MA (1988) Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia 8:83–91. https://doi.org/10.1046/j.1468-2982.1988.0802083.x PubMedCrossRef

77.

Hökfelt T, Johansson O, Goldstein M (1984) Chemical anatomy of the brain. Science 225:1326–1334PubMedCrossRef

78.

Hökfelt T, Millhorn D, Seroogy K et al (1987) Coexistence of peptides with classical neurotransmitters. Experientia 43:768–780PubMedCrossRef

79.

Berg EA, Johnson RJ, Leeman SE et al (2000) Isolation and characterization of substance P-containing dense core vesicles from rabbit optic nerve and termini. J Neurosci Res 62:830–839. https://doi.org/10.1002/1097-4547(20001215)62:6<830::AID-JNR10>3.0.CO;2-E PubMedCrossRef

80.

Kummer W (1992) Ultrastructure of calcitonin gene-related peptide-immunoreactive nerve fibres in guinea-pig peribronchial ganglia. Regul Pept 37:135–142PubMedCrossRef

81.

Juliano RL, Carver K, Cao C, Ming X (2013) Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides. J Drug Target 21:27–43. https://doi.org/10.3109/1061186X.2012.740674 PubMedCrossRef

82.

Angers CG, Merz AJ (2011) New links between vesicle coats and Rab-mediated vesicle targeting. Semin Cell Dev Biol 22:18–26. https://doi.org/10.1016/j.semcdb.2010.07.003 PubMedCrossRef

83.

Sutton RB, Fasshauer D, Jahn R, Brunger AT (1998) Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature 395:347–353. https://doi.org/10.1038/26412 PubMedCrossRef

84.

Meng J, Wang J, Lawrence G, Dolly JO (2007) Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J Cell Sci 120:2864–2874. https://doi.org/10.1242/jcs.012211 PubMedCrossRef

85.

Krämer HH, Angerer C, Erbguth F et al (2003) Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin. J Neurol 250:188–193. https://doi.org/10.1007/s00415-003-0971-x PubMedCrossRef

86.

Tugnoli V, Capone JG, Eleopra R et al (2007) Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin. Pain 130:76–83. https://doi.org/10.1016/j.pain.2006.10.030 PubMedCrossRef

87.

Gazerani P, Staahl C, Drewes AM, Arendt-Nielsen L (2006) The effects of botulinum toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization. Pain 122:315–325. https://doi.org/10.1016/j.pain.2006.04.014 PubMedCrossRef

88.

Carmichael NME, Dostrovsky JO, Charlton MP (2010) Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin. Pain 149:316–324. https://doi.org/10.1016/j.pain.2010.02.024 PubMedCrossRef

89.

Marino MJ, Terashima T, Steinauer JJ et al (2014) Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior. Pain 155:674–684. https://doi.org/10.1016/j.pain.2013.12.009 PubMedCrossRef

90.

Cui M, Khanijou S, Rubino J, Aoki KR (2004) Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 107:125–133PubMedCrossRef

91.

Ramachandran R, Lam C, Yaksh TL (2015) Botulinum toxin in migraine: role of transport in trigemino-somatic and trigemino-vascular afferents. Neurobiol Dis 79:111–122. https://doi.org/10.1016/j.nbd.2015.04.011 PubMedCrossRef

92.

Durham PL, Cady R, Cady R (2004) Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 44:35–42—discussion 42–3. https://doi.org/10.1111/j.1526-4610.2004.04007.x PubMedCrossRef

93.

Meng J, Ovsepian SV, Wang J et al (2009) Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential. J Neurosci 29:4981–4992. https://doi.org/10.1523/JNEUROSCI.5490-08.2009 PubMedCrossRef

94.

Theoharides TC, Spanos C, Pang X et al (1995) Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology 136:5745–5750. https://doi.org/10.1210/endo.136.12.7588332 PubMedCrossRef

95.

Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A (2005) The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev 49:65–76. https://doi.org/10.1016/j.brainresrev.2004.11.006 PubMedCrossRef

96.

Dalkara T, Zervas NT, Moskowitz MA (2006) From spreading depression to the trigeminovascular system. Neurol Sci 27(Suppl 2):S86–S90. https://doi.org/10.1007/s10072-006-0577-z PubMedCrossRef

97.

Levy D (2012) Endogenous mechanisms underlying the activation and sensitization of meningeal nociceptors: the role of immuno-vascular interactions and cortical spreading depression. Curr Pain Headache Rep 16:270–277. https://doi.org/10.1007/s11916-012-0255-1 PubMedCrossRef

98.

Guo A, Vulchanova L, Wang J et al (1999) Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 11:946–958PubMedCrossRef

99.

Zhang X-C, Strassman AM, Burstein R, Levy D (2007) Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. J Pharmacol Exp Ther 322:806–812. https://doi.org/10.1124/jpet.107.123745 PubMedCrossRef

100.

Zhang X, Levy D, Kainz V et al (2011) Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol 69:855–865. https://doi.org/10.1002/ana.22329 PubMedPubMedCentralCrossRef

101.

Hanko J, Hardebo JE, Kåhrström J et al (1985) Calcitonin gene-related peptide is present in mammalian cerebrovascular nerve fibres and dilates pial and peripheral arteries. Neurosci Lett 57:91–95PubMedCrossRef

102.

Edwards RM, Stack EJ, Trizna W (1991) Calcitonin gene-related peptide stimulates adenylate cyclase and relaxes intracerebral arterioles. J Pharmacol Exp Ther 257:1020–1024PubMed

103.

Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL (1997) Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia 17:518–524. https://doi.org/10.1046/j.1468-2982.1997.1704518.x PubMedCrossRef

104.

Kurosawa M, Messlinger K, Pawlak M, Schmidt RF (1995) Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br J Pharmacol 114:1397–1402PubMedPubMedCentralCrossRef

105.

Messlinger K, Hanesch U, Kurosawa M et al (1995) Calcitonin gene related peptide released from dural nerve fibers mediates increase of meningeal blood flow in the rat. Can J Physiol Pharmacol 73:1020–1024PubMedCrossRef

106.

Goadsby PJ, Edvinsson L, Ekman R (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 23:193–196. https://doi.org/10.1002/ana.410230214 PubMedCrossRef

107.

Zagami AS, Goadsby PJ, Edvinsson L (1990) Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 16:69–75PubMedCrossRef

108.

Dux M, Sántha P, Jancsó G (2003) Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat. J Physiol Lond 552:859–867. https://doi.org/10.1113/jphysiol.2003.050633 PubMedPubMedCentralCrossRef

109.

Messlinger K, Fischer MJM, Lennerz JK (2011) Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine. Keio J Med 60:82–89PubMedCrossRef

110.

Lassen LH, Haderslev PA, Jacobsen VB et al (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54–61PubMedCrossRef

111.

Olesen J, Diener H-C, Husstedt IW et al (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104–1110. https://doi.org/10.1056/NEJMoa030505 PubMedCrossRef

112.

Ho TW, Mannix LK, Fan X et al (2008) Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 70:1304–1312. https://doi.org/10.1212/01.WNL.0000286940.29755.61 PubMedCrossRef

113.

Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183–187. https://doi.org/10.1002/ana.410280213 PubMedCrossRef

114.

Levy D, Burstein R, Strassman AM (2005) Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol 58:698–705. https://doi.org/10.1002/ana.20619 PubMedCrossRef

115.

Covasala O, Stirn SL, Albrecht S et al (2012) Calcitonin gene-related peptide receptors in rat trigeminal ganglion do not control spinal trigeminal activity. J Neurophysiol 108:431–440. https://doi.org/10.1152/jn.00167.2011 PubMedCrossRef

116.

Bhatt DK, Ramachandran R, Christensen SLT et al (2015) CGRP infusion in unanesthetized rats increases expression of c-Fos in the nucleus tractus solitarius and caudal ventrolateral medulla, but not in the trigeminal nucleus caudalis. Cephalalgia 35:220–233. https://doi.org/10.1177/0333102414535995 PubMedCrossRef

117.

Rahmann A, Wienecke T, Hansen JM et al (2008) Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 28:226–236. https://doi.org/10.1111/j.1468-2982.2007.01497.x PubMedCrossRef

118.

Kruuse C, Thomsen LL, Birk S, Olesen J (2003) Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 126:241–247PubMedCrossRef

119.

Kruuse C, Thomsen LL, Jacobsen TB, Olesen J (2002) The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. J Cereb Blood Flow Metab 22:1124–1131. https://doi.org/10.1097/00004647-200209000-00010 PubMedCrossRef

120.

Markowitz S, Saito K, Moskowitz MA (1987) Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 7:4129–4136PubMedCrossRef

121.

Alvaro G, Di Fabio R (2007) Neurokinin 1 receptor antagonists—current prospects. Curr Opin Drug Discov Devel 10:613–621PubMed

122.

Shepherd SL, Williamson DJ, Beer MS et al (1997) Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats. Neuropharmacology 36:525–533PubMedCrossRef

123.

Buzzi MG, Moskowitz MA (1990) The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 99:202–206PubMedPubMedCentralCrossRef

124.

Moskowitz MA (1992) Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 13:307–311PubMedCrossRef

125.

Goldstein DJ, Wang O, Saper JR et al (1997) Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Cephalalgia 17:785–790. https://doi.org/10.1046/j.1468-2982.1997.1707785.x PubMedCrossRef

126.

Diener H (2003) RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia 23:183–185. https://doi.org/10.1046/j.1468-2982.2003.00496.x PubMedCrossRef

127.

Goldstein DJ, Roon KI, Offen WW et al (2001) Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial. Lancet 358:1230–1234PubMedCrossRef

128.

Petersen LJ, Church MK, Skov PS (1997) Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study. Clin Exp Allergy 27:284–295PubMedCrossRef

129.

Petersen LJ (1997) Quantitative measurement of extracellular histamine concentrations in intact human skin in vivo by the microdialysis technique: methodological aspects. Allergy 52:547–555PubMedCrossRef

130.

Weidner C, Klede M, Rukwied R et al (2000) Acute effects of substance P and calcitonin gene-related peptide in human skin—a microdialysis study. J Invest Dermatol 115:1015–1020. https://doi.org/10.1046/j.1523-1747.2000.00142.x PubMedCrossRef

131.

Gallai V, Alberti A, Gallai B et al (2003) Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia 23:166–174. https://doi.org/10.1046/j.1468-2982.2003.00552.x PubMedCrossRef

132.

Sarchielli P, Di Filippo M, Nardi K, Calabresi P (2007) Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep 11:343–351PubMedCrossRef

133.

deGroot J, Zhou S, Carlton SM (2000) Peripheral glutamate release in the hindpaw following low and high intensity sciatic stimulation. Neuroreport 11:497–502PubMedCrossRef

134.

Kidd BL, Urban LA (2001) Mechanisms of inflammatory pain. Br J Anaesth 87:3–11PubMedCrossRef

135.

Nordlind K, Johansson O, Lidén S, Hökfelt T (1993) Glutamate- and aspartate-like immunoreactivities in human normal and inflamed skin. Virchows Arch B Cell Pathol 64:75–82CrossRef

136.

Warncke T, Stubhaug A, Jørum E (2000) Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man. Pain 86:293–303PubMedCrossRef

137.

Cairns BE, Sessle BJ, Hu JW (1998) Evidence that excitatory amino acid receptors within the temporomandibular joint region are involved in the reflex activation of the jaw muscles. J Neurosci 18:8056–8064PubMedCrossRef

138.

Davidson EM, Carlton SM (1998) Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors. Brain Res 785:136–142PubMedCrossRef

139.

Davidson EM, Coggeshall RE, Carlton SM (1997) Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test. Neuroreport 8:941–946PubMedCrossRef

140.

Jackson DL, Graff CB, Richardson JD, Hargreaves KM (1995) Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats. Eur J Pharmacol 284:321–325PubMedCrossRef

141.

Lawand NB, Willis WD, Westlund KN (1997) Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats. Eur J Pharmacol 324:169–177PubMedCrossRef

142.

Carlton SM, Zhou S, Coggeshall RE (1998) Evidence for the interaction of glutamate and NK1 receptors in the periphery. Brain Res 790:160–169PubMedCrossRef

143.

Bhave G, Karim F, Carlton SM, Gereau RW (2001) Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci 4:417–423. https://doi.org/10.1038/86075 PubMedCrossRef

144.

Woo DH, Jung SJ, Zhu MH et al (2008) Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG). Mol Pain 4:42. https://doi.org/10.1186/1744-8069-4-42 PubMedPubMedCentralCrossRef

145.

Hu H-J, Bhave G, Gereau RW (2002) Prostaglandin and protein kinase A-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: potential mechanism for thermal hyperalgesia. J Neurosci 22:7444–7452PubMedCrossRef

146.

Juhasz G, Zsombok T, Jakab B et al (2005) Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 25:179–183. https://doi.org/10.1111/j.1468-2982.2005.00836.x PubMedCrossRef

147.

Johnson KW, Phebus LA, Cohen ML (1998) Serotonin in migraine: theories, animal models and emerging therapies. Prog Drug Res 51:219–244PubMedCrossRef

148.

Durham PL, Sharma RV, Russo AF (1997) Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation. J Neurosci 17:9545–9553PubMedCrossRef

149.

Cutrer FM, Yu XJ, Ayata G et al (1999) Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis. Neuropharmacology 38:1043–1053PubMedCrossRef

150.

Thomsen LL, Olesen J (2001) Nitric oxide in primary headaches. Curr Opin Neurol 14:315–321PubMedCrossRef

151.

Ramachandran R, Bhatt DK, Ploug KB et al (2012) A naturalistic glyceryl trinitrate infusion migraine model in the rat. Cephalalgia 32:73–84. https://doi.org/10.1177/0333102411430855 PubMedCrossRef

152.

Lassen LH, Ashina M, Christiansen I et al (1997) Nitric oxide synthase inhibition in migraine. Lancet 349:401–402PubMedCrossRef

153.

Zhang X, Kainz V, Zhao J et al (2013) Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors. Ann Neurol 73:741–750. https://doi.org/10.1002/ana.23873 PubMedPubMedCentralCrossRef

154.

McIlvried LA, Cruz JA, Borghesi LA, Gold MS (2016) Sex-, stress-, and sympathetic post-ganglionic-dependent changes in identity and proportions of immune cells in the dura. Cephalalgia. https://doi.org/10.1177/0333102416637832

155.

Dimlich RV, Keller JT, Strauss TA, Fritts MJ (1991) Linear arrays of homogeneous mast cells in the dura mater of the rat. J Neurocytol 20:485–503PubMedCrossRef

156.

Sicuteri F, Ricci M, Monfardini R, Ficini M (1957) Experimental headache with endogeneous histamine; first results obtained by 48/80, a histamine-liberator drug, in the cephalic and peripheral circulatory systems of man. Physiol Asp Clin Neurol 11:188–192

157.

Monro J, Carini C, Brostoff J (1984) Migraine is a food-allergic disease. Lancet 2:719–721PubMedCrossRef

158.

Smith JH, Butterfield JH, Cutrer FM (2011) Primary headache syndromes in systemic mastocytosis. Cephalalgia 31:1522–1531. https://doi.org/10.1177/0333102411421683 PubMedCrossRef

159.

Bigal ME, Sheftell FD, Rapoport AM et al (2002) Chronic daily headache: identification of factors associated with induction and transformation. Headache 42:575–581. https://doi.org/10.1046/j.1526-4610.2002.02143.x PubMedCrossRef

160.

Schwartz LB (1987) Mediators of human mast cells and human mast cell subsets. Ann Allergy 58:226–235PubMed

161.

Theoharides TC, Alysandratos K-D, Angelidou A et al (2012) Mast cells and inflammation. Biochim Biophys Acta (BBA) - Mol Basis Dis 1822:21–33. https://doi.org/10.1016/j.bbadis.2010.12.014 CrossRef

162.

Gri G, Frossi B, D'Inca F et al (2012) Mast cell: an emerging partner in immune interaction. Front Immunol 3:120. https://doi.org/10.3389/fimmu.2012.00120 PubMedPubMedCentralCrossRef

163.

Aich A, Feindel WH, Gupta K (2015) Mast cell-mediated mechanisms of nociception. Int J Mol Sci 16:29069–29092. https://doi.org/10.3390/ijms161226151 PubMedPubMedCentralCrossRef

164.

Perini F, D'Andrea G, Galloni E et al (2005) Plasma cytokine levels in migraineurs and controls. Headache 45:926–931. https://doi.org/10.1111/j.1526-4610.2005.05135.x PubMedCrossRef

165.

Sarchielli P, Alberti A, Baldi A et al (2006) Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46:200–207. https://doi.org/10.1111/j.1526-4610.2006.00337.x PubMedCrossRef

166.

Rozen T, Swidan SZ (2007) Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache 47:1050–1055. https://doi.org/10.1111/j.1526-4610.2006.00722.x PubMedCrossRef

167.

Ottosson A, Edvinsson L (1997) Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia 17:166–174. https://doi.org/10.1046/j.1468-2982.1997.1703166.x PubMedCrossRef

168.

Rozniecki JJ, Dimitriadou V, Lambracht-Hall M et al (1999) Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res 849:1–15PubMedCrossRef

169.

Groetzner P, Weidner C (2010) The human vasodilator axon reflex—an exclusively peripheral phenomenon? Pain 149:71–75. https://doi.org/10.1016/j.pain.2010.01.012 PubMedCrossRef

170.

Tani E, Senba E, Kokumai S et al (1990) Histamine application to the nasal mucosa induces release of calcitonin gene-related peptide and substance P from peripheral terminals of trigeminal ganglion: a morphological study in the guinea pig. Neurosci Lett 112:1–6PubMedCrossRef

171.

Levy D, Burstein R, Kainz V et al (2007) Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 130:166–176. https://doi.org/10.1016/j.pain.2007.03.012 PubMedPubMedCentralCrossRef

172.

Levy D, Kainz V, Burstein R, Strassman AM (2012) Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity. Brain Behav Immun 26:311–317. https://doi.org/10.1016/j.bbi.2011.09.016 PubMedCrossRef

173.

Zhang X-C, Kainz V, Burstein R, Levy D (2011) Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions. Pain 152:140–149. https://doi.org/10.1016/j.pain.2010.10.002 PubMedCrossRef

174.

Zhang X-C, Levy D (2008) Modulation of meningeal nociceptors mechanosensitivity by peripheral proteinase-activated receptor-2: the role of mast cells. Cephalalgia 28:276–284. https://doi.org/10.1111/j.1468-2982.2007.01523.x PubMedPubMedCentralCrossRef

175.

Baun M, Pedersen MHF, Olesen J, Jansen-Olesen I (2012) Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia 32:337–345. https://doi.org/10.1177/0333102412439354 PubMedCrossRef

176.

Pedersen SH, Ramachandran R, Amrutkar DV et al (2015) Mechanisms of glyceryl trinitrate provoked mast cell degranulation. Cephalalgia 35:1287–1297. https://doi.org/10.1177/0333102415574846 PubMedCrossRef

177.

Karatas H, Erdener SE, Gursoy-Ozdemir Y et al (2013) spreading depression triggers headache by activating neuronal Panx1 channels. Science 339:1092–1095. https://doi.org/10.1126/science.1231897 PubMedCrossRef

178.

Zhao J, Levy D (2015) Modulation of intracranial meningeal nociceptor activity by cortical spreading depression: a reassessment. J Neurophysiol 113:2778–2785. https://doi.org/10.1152/jn.00991.2014 PubMedPubMedCentralCrossRef

179.

Boes T, Levy D (2012) Influence of sex, estrous cycle, and estrogen on intracranial dural mast cells. Cephalalgia 32:924–931. https://doi.org/10.1177/0333102412454947 PubMedPubMedCentralCrossRef

180.

Zaitsu M, Narita S-I, Lambert KC et al (2007) Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol 44:1977–1985. https://doi.org/10.1016/j.molimm.2006.09.030 PubMedCrossRef

181.

Woller SA, Ravula SB, Tucci FC et al (2016) Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: the role of TLR4 in the evolution of a persistent pain state. Brain Behav Immun 56:271–280. https://doi.org/10.1016/j.bbi.2016.03.026 PubMedPubMedCentralCrossRef

182.

Qi J, Buzas K, Fan H et al (2011) Painful pathways induced by TLR stimulation of dorsal root ganglion neurons. J Immunol 186:6417–6426. https://doi.org/10.4049/jimmunol.1001241 PubMedPubMedCentralCrossRef

183.

Lin J-J, Du Y, Cai W-K et al (2015) Toll-like receptor 4 signaling in neurons of trigeminal ganglion contributes to nociception induced by acute pulpitis in rats. Sci Rep 5:12549. https://doi.org/10.1038/srep12549 PubMedPubMedCentralCrossRef

184.

Ohara K, Shimizu K, Matsuura S et al (2013) Toll-like receptor 4 signaling in trigeminal ganglion neurons contributes tongue-referred pain associated with tooth pulp inflammation. J Neuroinflammation 10:139. https://doi.org/10.1186/1742-2094-10-139 PubMedPubMedCentralCrossRef

185.

Wei X, Melemedjian OK, DD-U A et al (2014) Dural fibroblasts play a potential role in headache pathophysiology. Pain 155:1238–1244. https://doi.org/10.1016/j.pain.2014.03.013 PubMedPubMedCentralCrossRef

186.

Liu T, Gao Y-J, Ji R-R (2012) Emerging role of Toll-like receptors in the control of pain and itch. Neurosci Bull 28:131–144. https://doi.org/10.1007/s12264-012-1219-5 PubMedPubMedCentralCrossRef

187.

Fazzari J, Linher-Melville K, Singh G (2017) Tumour-derived glutamate: linking aberrant cancer cell metabolism to peripheral sensory pain pathways. Curr Neuropharmacol 15:620–636. https://doi.org/10.2174/1570159X14666160509123042 PubMedPubMedCentralCrossRef

188.

Nicolodi M, Sicuteri F (1992) Chronic naloxone administration, a potential treatment for migraine, enhances morphine-induced miosis. Headache 32:348–352. https://doi.org/10.1111/j.1526-4610.1992.hed3207348.x PubMedCrossRef

189.

Centonze V, Brucoli C, Macinagrossa G et al (1983) Non-familial hemiplegic migraine responsive to naloxone. Cephalalgia 3:125–127. https://doi.org/10.1046/j.1468-2982.1983.0302125.x PubMedCrossRef

190.

Sicuteri F, Boccuni M, Fanciullacci M, Gatto G (1983) Naloxone effectiveness on spontaneous and induced perceptive disorders in migraine. Headache 23:179–183. https://doi.org/10.1111/j.1526-4610.1983.hed2304179.x PubMedCrossRef

191.

Lewis SS, Loram LC, Hutchinson MR et al (2012) (+)-Naloxone, an opioid-inactive Toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats. J Pain 13:498–506. https://doi.org/10.1016/j.jpain.2012.02.005 PubMedPubMedCentralCrossRef

192.

Hutchinson MR, Northcutt AL, Hiranita T (2012) Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J Neurosci 32(33):11187–200

Title: Neurogenic inflammation and its role in migraine
Author: Roshni Ramachandran
Publication date: 01-05-2018
Publisher: Springer Berlin Heidelberg
Published in: Seminars in Immunopathology / Issue 3/2018
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-018-0676-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

Skin neurogenic inflammation

Antidromic neurogenic activity and cutaneous bacterial flora

Neurogenic inflammation in fibromyalgia

Origins of antidromic activity in sensory afferent fibers and neurogenic inflammation

Role of neurogenic inflammation in local communication in the visceral mucosa

Complexity of systems and actions underlying neurogenic inflammation

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage